{"slideshow_credits": null, "snippet": "The Chinese government said employees of the British drug giant had used bribes, taken kickbacks and committed other crimes to bolster drug sales.", "abstract": "Chinese investigators say executives at British drug giant GlaxoSmithKline have admitted to using bribes, kickbacks and other fraudulent means to bolster drug sales in China.", "section_name": "Business Day", "print_page": "1", "document_type": "article", "byline": {"person": [{"firstname": "David", "role": "reported", "lastname": "BARBOZA", "rank": 1, "organization": ""}], "original": "By DAVID BARBOZA", "contributor": "Stephanie Yifan Yang contributed research."}, "web_url": "http://www.nytimes.com/2013/07/12/business/global/china-accuses-glaxosmithkline-of-corruption.html", "lead_paragraph": "The Chinese government said employees of the British drug giant had used bribes, taken kickbacks and committed other crimes to bolster drug sales.", "headline": {"main": "GlaxoSmithKline Accused of Corruption by China", "print_headline": "GlaxoSmithKline Accused Of Corruption by China"}, "_id": "51de91ea7e0d9c0839d2f2ca", "word_count": "884", "multimedia": [{"height": 126, "url": "images/2013/07/12/business/global/12iht-bribe/12iht-bribe-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2013/07/12/business/global/12iht-bribe/12iht-bribe-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 400, "url": "images/2013/07/12/business/global/12iht-bribe/12iht-bribe-articleLarge.jpg", "legacy": {"xlarge": "images/2013/07/12/business/global/12iht-bribe/12iht-bribe-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "400"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2013/07/12/business/global/12iht-bribe/12iht-bribe-thumbStandard.jpg", "legacy": {"thumbnail": "images/2013/07/12/business/global/12iht-bribe/12iht-bribe-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2013-07-12T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "Corruption (Institutional)", "name": "subject", "is_major": "N", "rank": "1"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "is_major": "Y", "rank": "2"}, {"value": "GlaxoSmithKline PLC", "name": "organizations", "is_major": "Y", "rank": "3"}, {"value": "China", "name": "glocations", "is_major": "Y", "rank": "4"}, {"value": "Bribery and Kickbacks", "name": "subject", "is_major": "Y", "rank": "5"}], "blog": [], "subsection_name": "Global Business", "type_of_material": "News"}